Literature DB >> 16639390

Wolfram/DIDMOAD syndrome, a heterogenic and molecularly complex neurodegenerative disease.

Enric Domenech1, Montse Gomez-Zaera, Virginia Nunes.   

Abstract

Wolfram syndrome (WS, OMIM 22233), is a rare, autosomal recessive, and neurodegenerative disease. The syndrome is also known as DIDMOAD, the acronym for diabetes insipidus diabetes mellitus, optic atrophy and deafness, which summarizes the main clinical features, among many others, in WS patients. The gene associated with the syndrome, called WFS1, is located in the 4p16.1 region. The WFS1 gene encodes for a transmembrane protein located in the endoplasmic reticulum. Although the function of the WFS1 protein remains unknown, it is thought to be related with intracellular calcium homeostasis. The pattern of presentation of WS suggested the existence of mitochondrial impairment. Mitochondrial DNA rearrangements were detected in some patients, thus confirming that hypothesis. Recently, a particular WS phenotype has been described linked with the long arm of chromosome 4. This work aims to summarize the current knowledge about this disease that causes a heterogeneous phenotype and has a complex molecular aetiology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639390

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  11 in total

Review 1.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

Review 2.  Collaboration for rare diabetes: understanding new treatment options for Wolfram syndrome.

Authors:  Felix Reschke; Julia Rohayem; Pietro Maffei; Francesca Dassie; Anke Schwandt; Carine de Beaufort; Sonia Toni; Agnieszka Szypowska; Roque Cardona-Hernandez; Nicolin Datz; Katharina Klee; Thomas Danne
Journal:  Endocrine       Date:  2021-02-01       Impact factor: 3.633

Review 3.  Type 2 diabetes: new genes, new understanding.

Authors:  Inga Prokopenko; Mark I McCarthy; Cecilia M Lindgren
Journal:  Trends Genet       Date:  2008-10-25       Impact factor: 11.639

4.  Wolfram syndrome: a clinicopathologic correlation.

Authors:  Justin B Hilson; Saumil N Merchant; Joe C Adams; Jeffrey T Joseph
Journal:  Acta Neuropathol       Date:  2009-05-16       Impact factor: 17.088

5.  Type II diabetes increases mitochondrial DNA mutations in the left ventricle of the Goto-Kakizaki diabetic rat.

Authors:  S Hicks; N Labinskyy; B Piteo; D Laurent; J E Mathew; S A Gupte; J G Edwards
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-02-01       Impact factor: 4.733

6.  Significant expressivity of Wolfram syndrome: phenotypic assessment of two known and one novel mutation in the WFS1 gene in three Iranian families.

Authors:  Maryam Sobhani; Mohammad Amin Tabatabaiefar; Asadollah Rajab; Abdol-Mohammad Kajbafzadeh; Mohammad Reza Noori-Daloii
Journal:  Mol Biol Rep       Date:  2014-08-31       Impact factor: 2.316

7.  Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice.

Authors:  Yi-Fan Chen; Cheng-Heng Kao; Ya-Ting Chen; Chih-Hao Wang; Chia-Yu Wu; Ching-Yen Tsai; Fu-Chin Liu; Chu-Wen Yang; Yau-Huei Wei; Ming-Ta Hsu; Shih-Feng Tsai; Ting-Fen Tsai
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

8.  Quantification of mitochondrial DNA (mtDNA) damage and error rates by real-time QPCR.

Authors:  John G Edwards
Journal:  Mitochondrion       Date:  2008-12-07       Impact factor: 4.160

9.  Expression and localization of Wolfram syndrome 1 gene in the developing rat pancreas.

Authors:  Rong Xu; Biao Xia; Jie Geng; Jing Shi; Hui Shi; Li Yuan; Wei De
Journal:  World J Gastroenterol       Date:  2009-11-21       Impact factor: 5.742

Review 10.  Clinical Spectrum Associated with Wolfram Syndrome Type 1 and Type 2: A Review on Genotype-Phenotype Correlations.

Authors:  Maurizio Delvecchio; Matteo Iacoviello; Antonino Pantaleo; Nicoletta Resta
Journal:  Int J Environ Res Public Health       Date:  2021-04-30       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.